DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 55 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,381,414 | -8.2% | 10,294 | -1.5% | 0.37% | -12.4% |
| Q3 2023 | $2,593,637 | -2.4% | 10,454 | -5.6% | 0.42% | -2.6% |
| Q2 2023 | $2,657,760 | +90794.7% | 11,074 | -4.5% | 0.43% | -12.4% |
| Q1 2023 | $2,924 | -99.9% | 11,600 | -38.0% | 0.49% | -10.2% |
| Q1 2020 | $2,591,000 | -22.4% | 18,718 | -14.0% | 0.55% | -3.0% |
| Q4 2019 | $3,341,000 | +7.4% | 21,767 | +1.0% | 0.56% | +2.9% |
| Q3 2019 | $3,112,000 | -1.7% | 21,550 | -2.7% | 0.55% | -5.8% |
| Q2 2019 | $3,165,000 | +7.8% | 22,148 | -0.4% | 0.58% | +3.7% |
| Q1 2019 | $2,935,000 | +21.2% | 22,231 | -5.3% | 0.56% | +9.8% |
| Q4 2018 | $2,422,000 | -4.5% | 23,483 | +0.6% | 0.51% | +13.5% |
| Q3 2018 | $2,537,000 | +7.5% | 23,348 | -2.4% | 0.45% | -0.4% |
| Q2 2018 | $2,360,000 | -2.4% | 23,915 | -3.2% | 0.45% | +46.6% |
| Q1 2018 | $2,419,000 | +48.7% | 24,710 | +41.0% | 0.31% | +5.1% |
| Q4 2017 | $1,627,000 | +2.2% | 17,526 | -5.6% | 0.29% | -3.0% |
| Q3 2017 | $1,592,000 | +12.9% | 18,562 | +11.1% | 0.30% | +4.8% |
| Q2 2017 | $1,410,000 | -6.9% | 16,705 | -5.6% | 0.29% | -35.3% |
| Q1 2017 | $1,514,000 | +8.9% | 17,705 | -0.9% | 0.45% | +7.2% |
| Q4 2016 | $1,390,000 | -4.4% | 17,865 | -3.7% | 0.42% | -0.7% |
| Q3 2016 | $1,454,000 | -22.4% | 18,545 | 0.0% | 0.42% | -21.2% |
| Q2 2016 | $1,873,000 | +5.9% | 18,545 | -0.5% | 0.53% | +2.9% |
| Q1 2016 | $1,768,000 | +2.6% | 18,635 | +0.4% | 0.52% | -1.7% |
| Q4 2015 | $1,724,000 | +9.3% | 18,560 | +0.3% | 0.53% | +4.4% |
| Q3 2015 | $1,577,000 | -0.4% | 18,510 | 0.0% | 0.50% | +8.8% |
| Q2 2015 | $1,584,000 | +0.8% | 18,510 | 0.0% | 0.46% | -1.7% |
| Q1 2015 | $1,571,000 | +2.3% | 18,510 | +3.4% | 0.47% | -3.7% |
| Q4 2014 | $1,535,000 | +12.9% | 17,910 | +0.0% | 0.49% | +8.6% |
| Q3 2014 | $1,360,000 | -2.9% | 17,905 | +0.6% | 0.45% | -3.2% |
| Q2 2014 | $1,401,000 | +4.9% | 17,795 | 0.0% | 0.47% | +3.1% |
| Q1 2014 | $1,335,000 | +0.7% | 17,795 | +3.6% | 0.45% | -3.2% |
| Q4 2013 | $1,326,000 | +10.4% | 17,170 | -0.9% | 0.47% | +2.2% |
| Q3 2013 | $1,201,000 | +9.9% | 17,320 | +0.3% | 0.46% | +7.0% |
| Q2 2013 | $1,093,000 | – | 17,265 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |